02/06/2017 - 3:39pm

NACDS leadership also urges attendees to take part in RxIMPACT Day on Capitol Hill next month.

02/06/2017 - 2:03pm

Nationwide during the week ended Jan. 28, 3.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness.

02/06/2017 - 12:51pm

Already CRN has made significant progress in connecting to the 60 freshman Congressional leaders within the first 100 days, a promise CRN president and CEO Steve Mister shared with Drug Store News at the top of the year.

02/03/2017 - 4:44pm

The Pharmaceutical Research and Manufacturers of America has announced leadership changes to some of its advocacy efforts as longtime SVP advocacy Jeff Bond is set to retire. 

02/03/2017 - 10:51am

Overall, 88% of Americans believe that the benefits of inoculations, specifically MMR vaccines, outweigh the risks, the Pew Research Center reported.

02/02/2017 - 3:29pm

As 2016 drew to a close, the Food and Drug Administration gave a gift of sorts to drug makers looking to submit to the agency an application for approval of a biosimilar drug when it issued its final guidance, “Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product.”

02/02/2017 - 3:28pm

Generics have made a huge difference to the U.S. healthcare system’s bottom line in the past decade, a savings that takes 13 figures to tabulate.

01/31/2017 - 2:54pm

Executives from several the pharmaceutical industry convened at the White House Tuesday for a meeting with President Donald Trump, Vice President Mike Pence and House Energy and Commerce Committee chairman Rep. Greg Walden, R-Ore. 

01/31/2017 - 1:06pm

Sunshine State News is reporting that U.S. Reps. Gus Bilirakis, R-Fla., and Kurt Schrader, D-Ore., have introduced the Lower Drug Costs Through Competition Act, which is aimed at encouraging generics makers to develop generics of products with little or no competition, or for drugs that are in short supply. The bill calls for the creation of a Priority Review Voucher for generics applications filed for drugs that have no current competition. The bill was referred to the House Energy and Commerce Committee Monday, and eight representatives have signed on. (Sunshine State News)